KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

HCA Healthcare (HCA) EBITDA Margin (2016 - 2025)

HCA Healthcare (HCA) has disclosed EBITDA Margin for 16 consecutive years, with 15.91% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 4174.0% to 15.91% in Q4 2025 year-over-year; TTM through Dec 2025 was 2.03%, a 79.0% increase, with the full-year FY2025 number at 7.37%, up 17.0% from a year prior.
  • EBITDA Margin was 15.91% for Q4 2025 at HCA Healthcare, up from 19.69% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 17.73% in Q4 2022 to a low of 25.84% in Q4 2024.
  • A 5-year average of 5.84% and a median of 9.58% in 2022 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: plummeted -3697bps in 2024, then surged 4174bps in 2025.
  • HCA Healthcare's EBITDA Margin stood at 13.89% in 2021, then rose by 28bps to 17.73% in 2022, then plummeted by -37bps to 11.14% in 2023, then crashed by -332bps to 25.84% in 2024, then soared by 162bps to 15.91% in 2025.
  • Per Business Quant, the three most recent readings for HCA's EBITDA Margin are 15.91% (Q4 2025), 19.69% (Q3 2025), and 2.31% (Q2 2025).